🇺🇸 FDA
Patent

US 8481511

Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process

granted A61KA61K31/337A61K47/6951

Quick answer

US patent 8481511 (Pharmaceutical composition containing docetaxel-cyclodextrin inclusion complex and its preparing process) held by Hainan Hdeton Science and Technology Co., Ltd. expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Hainan Hdeton Science and Technology Co., Ltd.
Grant date
Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/337, A61K47/6951, A61K9/0019, A61P